Asthma and Chronic Sickle Cell Lung Disease: A Dynamic Relationship

Paediatric Respiratory Reviews

Volumn 12, Issue 1, 2011, Pages 78-82

  Shilo, N R ^a   Lands, L C ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Acute chest syndrome; Airway hyper reactivity; Sickle cell disease; Sickle cell lung disease

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; DEXAMETHASONE; NITRIC OXIDE; PEPTIDOLEUKOTRIENE; PLACEBO;

ACUTE CHEST SYNDROME; AIRWAY OBSTRUCTION; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; HYPOXIA; INFLAMMATION; INHALATION TEST; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; SICKLE CELL LUNG DISEASE;

ADOLESCENT; ANEMIA, SICKLE CELL; ASTHMA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT;

EID: 78650254197     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2010.09.007     Document Type: Review

References (39)

1. Graham L.M. Sickle Cell Disease: Pulmonary Management Options. Ped Pulm 2004, Suppl 26:S191-S193.
2. Gladwin M.T., Vichinsky E. Pulmonary Complications of Sickle Cell Disease. NEJM. 2008, 359:2254-2265.
3. Knight J., Murphy T.M., Browning I. The Lung in Sickle Cell Disease. Pediatr Pulm. 1999, 28:205-216.
4. Vichinsky E., Neumayer L.D., Earles A.N., et al. Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease. NEJM. 2000, 342:1855-1865. The National Acute Chest Syndrome Study Group.
5. Morris C.R. Asthma management: reinventing the wheel in sickle cell disease. Am J Hematol. 2009, 84:234-241.
6. Sylvester K.P., Patey R.A., Broughton S., et al. Temporal Relationship of Asthma to Acute Chest Syndrome in Sickle Cell Disease. Pediatr Pulmonol. 2007, 42:103-106.
7. Boyd J.H., Macklin E.A., Strunk R.C., DeBaun M.R. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood. 2006, 108:2923-2927.
8. Nandedkar S.D., Feroah T.R., Hutchins W., et al. Histopathology of experimentally induced asthma in a murine model of sickle cell disease. Blood. 2008, 112:2529-2538.
9. Koumbourlis A.C., Hurlet-Jensen A., Bye M.R. Lung Function in Infants with Sickle Cell Disease. Pediatr Pulm. 1997, 24:277-281.
10. Boyd J.H., DeBaun M.R., Morgan W.J., Mao J., Strunk R.C. Lower Airway Obstruction is Associated with Increase Morbidity in Children with Sickle Cell Disease. Pediatr Pulm. 2009, 44:290-296.
11. Koumbourlis A.C., Zar H.J., Hurlet-Jensen A., Goldberg M.R. Prevelence and reversibility of lower airway obstruction in children with sickle cell disease. J Pediatr. 2001, 138:188-192.
12. Koumbourlis A.C., Lee D.J., Lee A. Longitudinal Changes in Lung Function and Somatic Growth in Children with Sickle Cell Disease. Pediatr Pulm. 2007, 42:483-488.
13. MacLean J.E., Atenafu E., Kirby-Allen M., et al. Longitudinal Decline in Lung Volume in a Population of Children with Sickle Cell Disease. Am J Resp Crit Care. 2008, 178:1055-1059.
14. Leong M.A., Dampier C., Varlotta L., Allen J.L. Airway hyper-reactivity in children with sickle cell disease. J Pediatr. 1997, 131:278-283.
15. Strunk R.C., Brown M.S., Boyd J.H., Bates P., Field J.J., DeBaun M.R. Methacholine Challenge in Children with Sickle Cell Disease: A Case Series. Pediatr Pulm. 2008, 43:924-929.
16. Ozbek O.Y., Malbora B., Sen N., Yazici A.C., Ozyurek E., Ozbek N. Airway Hyper-reactivity Detected by Methacholine Challenge in Children with Sickle Cell Disease. Pediatr Pulm. 2007, 42:1187-1192.
17. Sylvester K.P., Patey R.A., Rafferty G.F., Rees D., Thein S.L., Greenough A. Airway Hyperresponsiveness and Acute Chest Syndrome in Children with Sickle Cell Disease. Pediatr Pulm. 2007, 42:272-276.
18. Knight-Madden J.M., Forrester T.S., Lewis N.A., Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax. 2005, 60:206-210.
19. Miller S.T., Sleeper L.A., Pegelow C.H., et al. Prediction of adverse outcomes in children with sickle cell disease. NEJM. 2000, 342:83-89.
20. Holtzclaw J.D., Jack D., Aguayo S.M., Eckman J.R., Roman J., Hsu L.L. Enhanced Pulmonary and Systemic Response to Endotoxin in Transgenic Sickle Mice. Am J Crit Care Med. 2004, 169:687-695.
21. Kaul DK, Hebbel RP, Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 2000; 106: 411-20. Platt OS (commentary). Sickle cell anemia as an inflammatory disease. J Clin Invest. 2000: 106: 337-8.
22. Bellet P.S., Kalinyak K.A., Shukla R., Gelfand M.J., Rucknagel D.L. Incentive Spirometry to Prevent Acute Pulmonary Complications in Sickle Cell Diseases. NEJM. 1995, 333:699-703.
23. Styles L.A., Aarsman A.J., Vichinsky E.P., Kuypers F.A. Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease. Blood. 2000, 96:3276-3278.
24. Quinn C.T., Buchanan G.R. The acute chest syndrome of sickle cell disease. J Pediatr. 1999, 135:416-422.
25. Morris C.R., Kato G.J., Poljakovic M., et al. Dysregulated Arginine Metabolism, Haemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease. JAMA. 2005, 294:81-90.
26. Lara A., Khatri S.B., Wang Z., et al. National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Alterations of the Arginine Metabolome in Asthma. Am J Respir Crit Care Med. 2008, 178:673-681.
27. Maarsingh H., Zuidhof A.B., Bos I.S.T., et al. Arginase Inhibition Protests against Allergen-induced Airway Obstruction, Hyperresponsiveness, and Inflammation. Am J Respir Crit Care Med. 2008, 178:565-573.
28. Al Hajeri A., Serjeant G.R., Fedorowicz Z. Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. Cochrane Database of Systemic Reviews. 2008, 1:CD006957.
29. Knight-Madden J.M., Hambleton I.R. Inhaled bronchodilators for acute chest syndrome in peoplxe with sickle cell disease. Cochrane Database of Systematic Reviews. 2003, 3:CD003733.
30. Sobota A., Graham D.A., Heeney M., Neufeld E.J. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Am J Hematol. 2010, 00:0-10.
31. Bernini J.C., Rogers Z.R., Sandler E.S., Reisch J.S., Quinn C.T., Buchanan G.R. Beneficial Effect of Intravenous Dexamethasone in Children with Mild to Moderately Severe Acute Chest Syndrome Complicating Sickle Cell Disease. Blood. 1998, 92:3082-3089.
32. Frei-Jones M.J., Field J.J., DeBaun M.R. Risk Factors for Hospital Readmission Within 30 Days: A New Quality Measure for Children With Sickle Cell Disease. Pediatr Blood Cancer. 2009, 52:481-485.
33. Isakoff M.S., Lillo J.A., Hagstrom J.N. A Single Indrome: Lack of Rebound Pain With Dexamethasone Plus Transfusion Therapy. J Pediatr Hematol Oncol. 2008, 30:322-325.
34. Field J.J., DeBaun M.R. Asthma and sickle cell disease: two distinct diseases or part of the same process?. Hematology. 2009, 45-53.
35. Sylvester K.P., Patey R.A., Milligan P., et al. Impact of Acute Chest Syndrome on Lung Function of Children with Sickle Cell Disease. J Pediatr. 2006, 149:17-22.
36. Vichinsky E.P., Styles L.A., Colangelo L.H., Wright E.C., Castro O., Nickerson B. Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course. Blood. 1997, 89:1787-1792. the Cooperative Study of Sickle Cell Disease.
37. Peters-Golden M., Henderson W.R. Leukotrienes. NEJM. 2007, 357:1841-1854.
38. Minter K.R., Gladwin M.T. Pulmonary Complications of Sickle Cell Anemia. Am J Respir Crit Care Med. 2001, 164:2016-2019.
39. Jennings J.E., Ramkumar T., Mao J., et al. Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell diseases. Am. J Hematol. 2008, 83:640-643.